CLINICAL_TRIALS
trial_result
· 2015-03-19
Clinical Trial Update: Intratumoral Injection Of Alpha-Gal Glycosphingolipids [Phase 1]
Summary
Phase 1 clinical trial of intratumoral alpha-gal glycosphingolipids in metastatic melanoma has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Massachusetts, Worcester | Conditions: Metastatic Melanoma | Phase 1 | Status: COMPLETED